Skip to main content

Table 1 Clinicopathological characteristics of the study cohort

From: Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases

Clinicopathological characteristics SCC AC P - value
Number of patients 103 33
Age 0.103(#)
 Mean 44.25 41.39
 Min 24 23
 Max 81 72
FIGO stage 0.856
 IBI 60 (58.2) 20 (60.6)
  > = IBII 42 (40.8) 13 (39.4)  
 Missing 1 (1) 0 (0.0)
Tumor size 0.448
  < =4 cm 72 (69.9) 25 (75.8)
  > 4 cm 29 (28.2) 7 (21.2)
 Missing 2 (1.9) 1 (3.0)
Vaginal involvement 0.191*
 Yes 17 (16.5) 1 (3.0)
 No 84 (81.6) 22 (66.7)
 Missing 2 (1.9) 10 (30.3)
Parametrium invasion 0.122
 Yes 38 (36.9) 7 (21.2)
 No 63 (61.2) 24 (72.7)
 Missing 2 (1.9) 2 (6.1)
Progression 0.303
 Yes 32 (31.1) 13 (39.4)
 No 65 (63.1) 14 (42.4)
 Missing 6 (5.8) 6 (18.2)
Recurrence in 5 years 0.014
 Yes 30 (29.1) 18 (54.5)
 No 64 (62.1) 14 (42.4)
 Missing 9 (8.7) 1 (3.0)
  1. Progression: determined by physical examination, pathological or radiological assessment
  2. Recurrence: recurrence after a complete remission due to the treatment
  3. P-value measured with Asymptotic Pearson Chi2; (*)Exact test was used when counts were less than 5; (#)Mann-Whitney U Test was used for mean comparison
  4. Data shown as n (%)
  5. FIGO International Federation of Gynecology and Obstetrics, SCC squamous cell carcinoma, AC adenocarcinoma